$200M gift propels scientific research in the search for life beyond earth
Legacy of Franklin Antonio represents quantum leap for The SETI Institute
2023-11-08
(Press-News.org)
$200m Gift Propels Scientific Research in the Search for Life Beyond Earth
Legacy of Franklin Antonio represents quantum leap for The SETI Institute
November 8, 2023, Mountain View, CA – The SETI Institute, a non-profit scientific research organization, announced today a philanthropic gift of $200m from the estate of Franklin Antonio, a visionary supporter and catalyst of the work of the SETI Institute for more than 12 years. Co-founder of communications chip company, Qualcomm, Antonio passed away on May 13, 2022, leaving behind an extraordinary legacy to enable breakthrough science in the search for intelligent life beyond our world.
With more than 100 scientists actively conducting research across 173 separate programs, the SETI Institute explores six key science disciplines: Astronomy and Astrophysics; Exoplanets; Planetary Exploration; Astrobiology; Climate and bio-geoscience; and the Search for Extraterrestrial Intelligence (SETI).
“Guided by our core mission and Franklin Antonio’s vision, we now have the opportunity to elevate and expedite our research and make new discoveries to benefit all humanity for generations to come,” said SETI Institutes President & CEO Bill Diamond. “In his memory, the SETI Institute will continue its pursuit of one of the biggest and most profound questions in all of science, a question as old as humanity itself – are we alone in the universe?”
This gift enables the SETI Institute to undertake more missions and expand research priorities to push the boundaries of human knowledge in exploring life beyond our planet and the origins of life here on Earth. Examples include:
Establish postdoctoral fellowships and internal grants for science and education programs
Enable the SETI Institute’s research base to expand and extend its reach globally through new international collaborations
Develop new educational programs and initiatives, particularly focused on reaching and engaging underserved communities
Support the development of innovative observational technologies and analytical instruments
“Not only was Franklin the primary benefactor of SETI research at the Allen Telescope Array (ATA), but he was an integral part of the technical team. His extraordinary knowledge of communications technology was invaluable in upgrading the ATA to the world-class radio telescope instrument it is today,” said Dr. Andrew Siemion, Bernard M. Oliver Chair of SETI Research at the SETI Institute and Director of SETI Research at the University of Oxford.
Currently, SETI-focused projects are eligible for only limited federal funding through research grants and otherwise depend entirely on philanthropic support and private funding. As such, Antonio’s gift will also serve to permanently endow core SETI programs and foster new global partnerships.
“This gift will impact all research domains of the SETI Institute,” said Dr. Nathalie Cabrol, Director of the Carl Sagan Center for Research. “It will provide our teams the freedom to pursue their own science priorities, and to examine the technological, philosophical and societal impact of their research on our daily lives here on Earth.”
###
About The SETI Institute
Founded in 1984, the SETI Institute is a non-profit, multi-disciplinary research and education organization whose mission is to lead humanity's quest to understand the origins and prevalence of life and intelligence in the universe and share that knowledge with the world. Our research encompasses the physical and biological sciences and leverages data analytics, machine learning, and advanced signal detection technologies. The SETI Institute is a distinguished research partner for industry, academia, and government agencies, including NASA the Department of Energy and the National Science Foundation. https://www.seti.org/
END
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
2023-11-08
(WASHINGTON, Nov. 8, 2023) – Using birth control pills and other hormone-based contraceptives is known to elevate the risk of blood clots about three-fold, but a new study suggests that this risk largely goes away within two to four weeks after one stops using these contraceptives, according to research published today in Blood.
The findings – the first to provide such confirmatory guidance on the best timing to stop contraception – can help patients and doctors weigh the benefits and risks of hormonal contraceptives and guide when to stop using them ahead of events that could further increase the risk of dangerous clots, such as major surgery, ...
2023-11-08
A new study published in Nutrients shows daily consumption of strawberries for 12 weeks reduced interference in memory and depressive symptoms among middle-aged, overweight adults with self-reported mild cognitive decline.
“Dementia is a general term that includes many different diseases, all without remedies,” says Robert Krikorian, Ph.D., principal investigator and professor in the department of psychiatry at the University of Cincinnati Academic Health Center. “It is not clear when ...
2023-11-08
Silicon (Si) is abundant in terrestrial environments and accounts for 0.1% to 10% of a plant’s dry weight. Certain plant species show high levels of Si accumulation, and research has identified high Si accumulation as a protective mechanism against abiotic (drought, cold, heat) and biotic stressors (living organisms). Oryza sativa (rice) can store Si to the tune of 10% of the dry weight of shoots (stem, leaves, flowers), and Si is vital for stable grain production. High degree of Si deposition is believed to mitigate against damage caused ...
2023-11-08
The American Pediatric Society (APS) is pleased to announce Glenn Flores, MD, as the 2024 David G. Nichols Health Equity Award recipient.
The David G. Nichols Health Equity Award, administered by the APS and endowed by the American Board of Pediatrics (ABP) Foundation, was created to recognize demonstrated excellence in advancing child and adolescent health, well-being, and equity through quality improvement, advocacy, practice, or research. This award recognizes Dr. Flores’ outstanding contributions to advancing child and adolescent health, well-being, and equity and the ...
2023-11-08
Under the ocean’s surface, marine organisms are constantly releasing invisible molecules. Some of the chemical clues reveal which creatures are nearby, while others could be used someday as medications. Now, researchers in ACS Central Science report a proof-of-concept device that “sniffs” seawater, trapping dissolved compounds for analyses. The team showed that the system could easily concentrate molecules that are present in underwater caves and holds promise for drug discovery in fragile ecosystems, including coral reefs.
A ...
2023-11-08
By rapidly reversing the effects of an opioid overdose, naloxone saves lives ― if it’s available at the right time. To eliminate this element of chance, researchers are exploring ways to have the medication available in the body before it’s needed. In a proof-of-concept in ACS’ Nano Letters, a team has designed injectable nanoparticles that released naloxone when triggered by blue light. In experiments with mice, this system was activated a month after injection.
Since it began more than two decades ago, the opioid epidemic has taken an enormous toll on people’s lives. In 2022 ...
2023-11-08
In patients with systemic sclerosis (SSc), a rare connective tissue disease, interstitial lung disease contributes to 35 percent of deaths. Published recently in the American Journal of Respiratory and Critical Care Medicine, the latest American Thoracic Society Clinical Practice Guideline makes a number of recommendations. One recommendation expands antifibrotic treatment to all patients with systemic sclerosis associated with ILD (SSc-ILD), not just those with progressive disease.
Watch the explainer video.
Lead guidelines chair and editor, Ganesh Raghu, M.D., ATSF, noted the timeliness of the recommendations given the many immune ...
2023-11-08
Central diabetes insipidus (CDI), a rare condition involving the destruction or degeneration of neurons of the hypothalamic-posterior pituitary in the brain, has several likely underlying clinical causes. Patients with CDI experience excessive thirst and excessive urine production, owing to the decreased secretion of AVP. Moreover, in children and young adults with CDI, a malignant tumor known as a 'germinoma' may develop later in life. The diagnosis of these tumors is challenging, because biopsy in intracranial lesions is difficult.
Lymphocytic infundibulo-neurohypophysitis (LINH) or ...
2023-11-08
General anesthesia evokes a dual mystery: How does it disrupt consciousness, including sensory perception, and what might that say about the nature of consciousness. A new study led by researchers at The Picower Institute for Learning and Memory at MIT provides evidence in animals that consciousness depends on properly synchronized communication across the brain’s cortex and that the anesthetic drug propofol cancels sensory processing by cutting it off.
In the Journal of Cognitive Neuroscience, researchers report clear evidence that in anesthetized animals, ...
2023-11-08
Genetic information collected from seemingly healthy tissue near lung tumors may be a better predictor of whether cancer will come back after treatment than analysis of the tumors themselves, according to new research led by NYU Langone Health and its Perlmutter Cancer Center.
The new study focuses on lung adenocarcinoma, a cancer that forms in alveolar epithelial cells and accounts for about a third of all lung cancers in the United States, according to the U.S. Centers for Disease Control and Prevention. Most patients are cured if tumors are surgically removed early in the disease’s progression, but residual ...
LAST 30 PRESS RELEASES:
[Press-News.org] $200M gift propels scientific research in the search for life beyond earth
Legacy of Franklin Antonio represents quantum leap for The SETI Institute
